These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3500261)

  • 1. Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).
    Widmer MB; Acres RB; Sassenfeld HM; Grabstein KH
    J Exp Med; 1987 Nov; 166(5):1447-55. PubMed ID: 3500261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.
    Widmer MB; Grabstein KH
    Nature; 1987 Apr 23-29; 326(6115):795-8. PubMed ID: 3494950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.
    Alderson MR; Sassenfeld HM; Widmer MB
    J Exp Med; 1990 Aug; 172(2):577-87. PubMed ID: 2142722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
    J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
    Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
    J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.
    Roth AD; Dupuis S; Alberto P
    Clin Exp Immunol; 1995 Aug; 101(2):362-8. PubMed ID: 7648722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of murine T cell proliferation by B cell stimulatory factor-1.
    Grabstein KH; Park LS; Morrissey PJ; Sassenfeld H; Price V; Urdal DL; Widmer MB
    J Immunol; 1987 Aug; 139(4):1148-53. PubMed ID: 3112226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.
    Fernandez-Botran R; Krammer PH; Diamantstein T; Uhr JW; Vitetta ES
    J Exp Med; 1986 Aug; 164(2):580-93. PubMed ID: 2941517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation.
    Alderson MR; Pike BL; Nossal GJ
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1389-93. PubMed ID: 3493492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes.
    Trenn G; Takayama H; Hu-Li J; Paul WE; Sitkovsky MV
    J Immunol; 1988 Feb; 140(4):1101-6. PubMed ID: 3257770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 mediates the generation and expansion of murine allosensitized and antitumor CTL.
    Jicha DL; Schwarz S; Mulé JJ; Rosenberg SA
    Cell Immunol; 1992 Apr; 141(1):71-83. PubMed ID: 1555257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.
    Brooks B; Rees RC
    Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interleukin 4 (RIL4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes.
    Han X; Itoh K; Balch CM; Pellis NR
    Lymphokine Res; 1988; 7(3):227-35. PubMed ID: 3263554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.